Ascletis Pharma (China) Co., Limited clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   ASC30 Tablets · Type 2 Diabetes Mellitus

   Trial completed

   Ascletis Pharma (China) Co., Limited·Phase 2· NCT07321678· Registry history of NCT07321678 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

2. Minor

   ASC50 Tables in Healthy Participants and · Plaque Psoriasis

   Trial completed

   Also in this update: Final enrollment: 55 participants (planned 94); Trial arms changed: 9 → 7

   Ascletis Pharma (China) Co., Limited·Phase 1· NCT07024602· Registry history of NCT07024602 on ClinicalTrials.gov (opens the registry)

   Sep 30, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.